These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24909126)

  • 1. Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosis.
    Villar LM; Casanova B; Ouamara N; Comabella M; Jalili F; Leppert D; de Andrés C; Izquierdo G; Arroyo R; Avşar T; Lapin SV; Johnson T; Montalbán X; Fernández O; Álvarez-Lafuente R; Masterman D; García-Sánchez MI; Coret F; Siva A; Evdoshenko E; Álvarez-Cermeño JC; Bar-Or A
    Ann Neurol; 2014 Aug; 76(2):231-40. PubMed ID: 24909126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
    Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
    Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
    Sola P; Mandrioli J; Simone AM; Ferraro D; Bedin R; Annecca R; Venneri MG; Nichelli PF; Merelli E
    Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
    Ferreira D; Voevodskaya O; Imrell K; Stawiarz L; Spulber G; Wahlund LO; Hillert J; Westman E; Karrenbauer VD
    J Neuroimmunol; 2014 Sep; 274(1-2):149-54. PubMed ID: 24999245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
    Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
    Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
    Koch M; Heersema D; Mostert J; Teelken A; De Keyser J
    Eur J Neurol; 2007 Jul; 14(7):797-800. PubMed ID: 17594338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.
    Farina G; Magliozzi R; Pitteri M; Reynolds R; Rossi S; Gajofatto A; Benedetti MD; Facchiano F; Monaco S; Calabrese M
    J Neuroinflammation; 2017 Feb; 14(1):40. PubMed ID: 28222766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
    J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
    Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
    Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
    Kelly SB; Kinsella K; Duggan M; Tubridy N; McGuigan C; Hutchinson M
    Mult Scler; 2013 Jul; 19(8):1095-100. PubMed ID: 23132903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
    Thangarajh M; Gomez-Rial J; Hedström AK; Hillert J; Alvarez-Cermeño JC; Masterman T; Villar LM
    Mult Scler; 2008 Nov; 14(9):1208-13. PubMed ID: 18755821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands.
    Vrethem M; Kvarnström M; Stenstam J; Cassel P; Gustafsson M; Landtblom AM; Ernerudh J
    Mult Scler; 2012 May; 18(5):669-73. PubMed ID: 21965416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal IgM-synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event.
    Schneider R; Euler B; Rauer S
    Eur J Neurol; 2007 Aug; 14(8):907-11. PubMed ID: 17662013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal oligoclonal IgG synthesis in multiple sclerosis.
    Petzold A
    J Neuroimmunol; 2013 Sep; 262(1-2):1-10. PubMed ID: 23890808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome.
    Ferraro D; Simone AM; Bedin R; Galli V; Vitetta F; Federzoni L; D'Amico R; Merelli E; Nichelli PF; Sola P
    J Neuroimmunol; 2013 Apr; 257(1-2):76-81. PubMed ID: 23434160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis.
    Andreadou E; Chatzipanagiotou S; Constantinides VC; Rombos A; Stamboulis E; Nicolaou C
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2094-8. PubMed ID: 23953642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal, polyspecific antiviral immune response in oligoclonal band negative multiple sclerosis.
    Brecht I; Weissbrich B; Braun J; Toyka KV; Weishaupt A; Buttmann M
    PLoS One; 2012; 7(7):e40431. PubMed ID: 22792316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients.
    Joseph FG; Hirst CL; Pickersgill TP; Ben-Shlomo Y; Robertson NP; Scolding NJ
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):292-6. PubMed ID: 18829628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
    Siritho S; Freedman MS
    J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
    Khademi M; Kockum I; Andersson ML; Iacobaeus E; Brundin L; Sellebjerg F; Hillert J; Piehl F; Olsson T
    Mult Scler; 2011 Mar; 17(3):335-43. PubMed ID: 21135023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.